Log in | Register

Abbott to Acquire Wockhardt Nutrition Businesses, Expanding Presence in India

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Abbott has announced a definitive agreement to acquire the nutrition businesses of WockhardtLimited, Carol Info Services Limited, and certain Wockhardt subsidiaries andgroup companies for consideration totaling approximately US$130 million incash.

Wockhardt, based in Mumbai, India, has a significant presence in India'spediatric and adult nutrition segments with infant formulas, weaning foods andadult protein supplements. These products hold the number two position inIndia's pediatric nutrition category with Farex , Dexolac and Nusobee infantformulas and Farex weaning cereal. The adult protein supplement, Protinex ,is the segment leader. These transactions also include nutrition manufacturingfacilities located in Lalru and Jagraon, India.

"This acquisition is an excellent strategic fit for Abbott to accelerategrowth of its nutrition business in India, where the nutritional market isexpected to experience strong growth in the coming years," said HolgerLiepmann, executive vice president, Global Nutrition, Abbott. "Combining thesetrusted nutrition products, local manufacturing capability and commercialinfrastructure with Abbott's existing pediatric and adult nutrition offeringspositions Abbott very well to serve Indian consumers."

Abbott's international nutrition business is an important growth driverfor the company and has had particularly strong growth in China, SoutheastAsia and Latin America in recent years.

The acquisition includes approximately 600 employees in total. Abbott hasapproximately 1,500 employees in India across all of its businesses and hasbeen operating in India since 1910. Abbott offers Isomil , PediaSure , Ensureand Glucerna in India and plans to introduce additional products from itsbroad-based nutritional portfolio to Indian consumers in the coming years.

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

When Is Software The Answer To Regulatory Concerns About Your Investigations?

When Is Software The Answer To Regulatory Concerns About Your Investigations?

Jan 30 | John Ager, Technical Consultant, Life Science, Kepner-Tregoe, Inc

Document management software enables investigators to present the information used to reach conclusions clearly and concisely and it helps reviewers to track and approve investigations.

The Benefits of Professional Project Management

The Benefits of Professional Project Management

Jan 13 | Thorsten Vammen, Director at GEA Liquid Processing in Skanderborg, Denmark

Some companies feel that they can project manage new processing facilities themselves, bringing in sub-contracted help only when it’s needed. Self-managing is possible, but there may be a better way.

Multimedia

Government Seeking $1T Campaign Against Alzheimer's

Government Seeking $1T Campaign Against Alzheimer's

Jan 18 | Video

Government advisors tried to set priorities for a national campaign to treat and manage Alzheimer's disease, which is projected to cost more than a trillion dollars in care by 2050. But as Dr. Jon LaPook reports, the plan does not include any funding.

ADHD Drugs in Short Supply

ADHD Drugs in Short Supply

Jan 11 | Video

Parents of children with attention deficit disorders are forced to travel from pharmacy to pharmacy in search of prescription medicines with no guarantees they will be available.

Study: Link Between Statins And Diabetes

Study: Link Between Statins And Diabetes

Jan 10 | Video

A recent study reveals that women who take statins may have a greate chance of developing diabetes.

Avastin Shows Promise in Fight Against Ovarian Cancer

Avastin Shows Promise in Fight Against Ovarian Cancer

Jan 5 | Video

Two recent studies show that Avastin, already approved for other cancers - but still controversial, could help women buy more time in their fight against ovarian cancer.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter